×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share
3093 views

Modérateur : Alexandre de Nonneville

Au programme de cette soirée

18:00 Introduction
 
18:05 Testing HER2, le point de vue de l'anapath
Camille Franchet
 
18:25 HER2-faible, une nouvelle entité dans le cancer du sein ?
Alexandre de Nonneville
 
18:45 Premières lignes des cancers du sein métastatiques HER2-faible
Ophélie Cassuto
 
19:05 Place et séquence des ADC dans les cancers du sein métastatiques HER2-faible
François Bertucci
 
19:25 Débat/discussion - Réponses aux questions
 

 


Webinar #1   Webinar #3

 

Shooting date : 2024-02-01
Last update : 2024-04-03

Suggestions

0
Days
0
Hours
0
Minutes
0
Seconds
Thursday, November 27th 2025 from 07:30pm to 09:30pm (GMT+1)
Honolulu : Thursday, November 27th 2025 from 07:30am to 09:30am (GMT+1)
San Francisco : Thursday, November 27th 2025 from 09:30am to 11:30am (GMT+1)
New York : Thursday, November 27th 2025 from 12:30pm to 02:30pm (GMT+1)
Buenos Aires : Thursday, November 27th 2025 from 02:30pm to 04:30pm (GMT+1)
London / Dublin : Thursday, November 27th 2025 from 05:30pm to 07:30pm (GMT+1)
Paris / Berlin : Thursday, November 27th 2025 from 06:30pm to 08:30pm (GMT+1)
Istanbul : Thursday, November 27th 2025 from 07:30pm to 09:30pm (GMT+1)
Moscou / Dubaï : Thursday, November 27th 2025 from 09:30pm to 11:30pm (GMT+1)
Bangkok : Friday, November 28th 2025 from 12:30am to 02:30am (GMT+1)
Shanghai : Friday, November 28th 2025 from 01:30am to 03:30am (GMT+1)
Tokyo : Friday, November 28th 2025 from 02:30am to 04:30am (GMT+1)
Sydney : Friday, November 28th 2025 from 03:30am to 05:30am (GMT+1)
Wellington : Friday, November 28th 2025 from 05:30am to 07:30am (GMT+1)

Cancers du sein HER2- métastatiques

Que retenir pour la pratique de demain ?

Thursday, October 13th 2022 from 06pm to 07pm (GMT+2)
Honolulu : Thursday, October 13th 2022 from 06am to 07am (GMT+2)
San Francisco : Thursday, October 13th 2022 from 09am to 10am (GMT+2)
New York : Thursday, October 13th 2022 from 12pm to 01pm (GMT+2)
Buenos Aires : Thursday, October 13th 2022 from 01pm to 02pm (GMT+2)
Reykjavik : Thursday, October 13th 2022 from 04pm to 05pm (GMT+2)
London / Dublin : Thursday, October 13th 2022 from 05pm to 06pm (GMT+2)
Paris / Berlin : Thursday, October 13th 2022 from 06pm to 07pm (GMT+2)
Istanbul : Thursday, October 13th 2022 from 07pm to 08pm (GMT+2)
Moscou / Dubaï : Thursday, October 13th 2022 from 08pm to 09pm (GMT+2)
Bangkok : Thursday, October 13th 2022 from 11pm to 12am (GMT+2)
Shanghai : Friday, October 14th 2022 from 12am to 01am (GMT+2)
Tokyo : Friday, October 14th 2022 from 01am to 02am (GMT+2)
Sydney : Friday, October 14th 2022 from 03am to 04am (GMT+2)
Wellington : Friday, October 14th 2022 from 05am to 06am (GMT+2)

Les inhibiteurs de tyrosine kinase (TKI) et les anticorps conjugués (ADC) dans le cancer du sein mÃ...

Les nouveaux traitements, entre choix et complémentarité

Share
Tuesday, March 28th 2023 from 07pm to 08:30pm (GMT+2)
Honolulu : Tuesday, March 28th 2023 from 07am to 08:30am (GMT+2)
San Francisco : Tuesday, March 28th 2023 from 10am to 11:30am (GMT+2)
New York : Tuesday, March 28th 2023 from 01pm to 02:30pm (GMT+2)
Buenos Aires : Tuesday, March 28th 2023 from 02pm to 03:30pm (GMT+2)
Reykjavik : Tuesday, March 28th 2023 from 05pm to 06:30pm (GMT+2)
London / Dublin : Tuesday, March 28th 2023 from 06pm to 07:30pm (GMT+2)
Paris / Berlin : Tuesday, March 28th 2023 from 07pm to 08:30pm (GMT+2)
Istanbul : Tuesday, March 28th 2023 from 08pm to 09:30pm (GMT+2)
Moscou / Dubaï : Tuesday, March 28th 2023 from 09pm to 10:30pm (GMT+2)
Bangkok : Wednesday, March 29th 2023 from 12am to 01:30am (GMT+2)
Shanghai : Wednesday, March 29th 2023 from 01am to 02:30am (GMT+2)
Tokyo : Wednesday, March 29th 2023 from 02am to 03:30am (GMT+2)
Sydney : Wednesday, March 29th 2023 from 04am to 05:30am (GMT+2)
Wellington : Wednesday, March 29th 2023 from 06am to 07:30am (GMT+2)

La prise en charge des cancers du sein triple négatifs :

intégration des innovations thérapeutiques dans les algorithmes et gestion des effets secondaires

Share
Tuesday, May 14th 2024 from 06pm to 07:30pm (GMT+2)
Honolulu : Tuesday, May 14th 2024 from 06am to 07:30am (GMT+2)
San Francisco : Tuesday, May 14th 2024 from 09am to 10:30am (GMT+2)
New York : Tuesday, May 14th 2024 from 12pm to 01:30pm (GMT+2)
Buenos Aires : Tuesday, May 14th 2024 from 01pm to 02:30pm (GMT+2)
Reykjavik : Tuesday, May 14th 2024 from 04pm to 05:30pm (GMT+2)
London / Dublin : Tuesday, May 14th 2024 from 05pm to 06:30pm (GMT+2)
Paris / Berlin : Tuesday, May 14th 2024 from 06pm to 07:30pm (GMT+2)
Istanbul : Tuesday, May 14th 2024 from 07pm to 08:30pm (GMT+2)
Moscou / Dubaï : Tuesday, May 14th 2024 from 08pm to 09:30pm (GMT+2)
Bangkok : Tuesday, May 14th 2024 from 11pm to 12:30am (GMT+2)
Shanghai : Wednesday, May 15th 2024 from 12am to 01:30am (GMT+2)
Tokyo : Wednesday, May 15th 2024 from 01am to 02:30am (GMT+2)
Sydney : Wednesday, May 15th 2024 from 03am to 04:30am (GMT+2)
Wellington : Wednesday, May 15th 2024 from 05am to 06:30am (GMT+2)

Développement thérapeutique dans les cancers du sein triples négatifs métastatiques

Les webinars du réseau FEM-NET

Share
Scroll Up